Illumina, Inc. (ILMN)
ILMNNASDAQ-GSMedical Specialities
$221.01
+0.2300 (+0.10%) today
At the close, Nov 9, 4:00 PM ET. Pre-market $220.43 -0.16%
- Market cap
- $33.33bn
- P/E
- 42.1
- EPS, last 4 quarters
- $5.25
- Dividend yield
- –
- Day range
- –
- 52-week range
- $112.65 to $309.35
- Average volume
- 3.08m
- Previous close
- $220.78
Analysts
18 coveringHold9 buy, 6 hold, 3 sell
Targets a year out average $260.89, +18.0% from here
Earnings
next estimate $1.52Next report
Dec 2025
+7.1%
Mar 2026
+9.5%
Jun 2026
+6.5%
Sep 2026
+5.9%
estimate reported, and the surprise
Financials
| Quarter | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| Revenue | $1.16bn | $1.09bn | $1.16bn | $1.13bn |
| Gross profit | $759.00m | $721.00m | $770.00m | $830.00m |
| Operating income | $201.00m | $209.00m | $245.00m | $305.00m |
| Net income | $334.00m | $134.00m | $206.00m | $221.00m |
Last four quarters: revenue $4.54bn, margin 19.7%, free cash flow $1.06bn
News
8 latest- iShares Biotechnology ETF Experiences Big OutflowBNK Invest · 22 hours ago
- REGN vs. ILMN: Which Stock Is the Better Value Option?Zacks · 6 days ago
- Illumina Expands Singapore Precision Medicine Partnership With SG-INSIGHT Study; Stock Up RTTNews · Nov 3, 2026
- 3 Stocks to Watch Following Guidance UpgradesZacks · Nov 2, 2026
- Why Illumina (ILMN) is a Top Growth Stock for the Long-TermZacks · Nov 2, 2026
- Don't Overlook Illumina (ILMN) International Revenue Trends While Assessing the StockZacks · Nov 2, 2026
- Alger AI Enablers & Adopters ETF Experiences Big InflowBNK Invest · Oct 30, 2026
- Illumina (ILMN) Q3 2026 Earnings Call TranscriptThe Motley Fool · Oct 30, 2026
The company
Illumina is improving human health by unlocking the power of the genome. Our focus on innovation has established us as a global leader in DNA sequencing and array-based technologies, serving customers in the research, clinical, and applied markets. Our products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments.
- Sector
- Health Care
- Industry
- Medical Specialities
- Exchange
- NASDAQ-GS
- Region
- North America
- Website
- illumina.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.